Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark

被引:64
|
作者
Lyngse, Frederik Plesner [1 ,2 ,3 ,4 ]
Kirkeby, Carsten Thure
Denwood, Matthew
Christiansen, Lasse Engbo [6 ]
Molbak, Kare [4 ,5 ]
Moller, Camilla Holten [4 ]
Skov, Robert Leo [4 ]
Krause, Tyra Grove [4 ]
Rasmussen, Morten [4 ]
Sieber, Raphael Niklaus [4 ]
Johannesen, Thor Bech [4 ]
Lillebaek, Troels [4 ,7 ]
Fonager, Jannik [4 ]
Fomsgaard, Anders [4 ]
Moller, Frederik Trier [4 ]
Stegger, Marc [4 ]
Overvad, Maria [4 ]
Spiess, Katja [4 ]
Mortensen, Laust Hvas [8 ,9 ]
机构
[1] Univ Copenhagen, Dept Econ, Copenhagen, Denmark
[2] Univ Copenhagen, Ctr Econ Behav & Inequal, Copenhagen, Denmark
[3] Danish Minist Hlth, Copenhagen, Denmark
[4] Statens Serum Inst, Copenhagen, Denmark
[5] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark
[6] Tech Univ Denmark, Dept Appl Math & Comp Sci Dynam Syst, Lyngby, Denmark
[7] Univ Copenhagen, Global Hlth Sect, Copenhagen, Denmark
[8] Stat Denmark, Copenhagen, Denmark
[9] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark
基金
新加坡国家研究基金会;
关键词
D O I
10.1038/s41467-022-33498-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
SARS coronavirus 2 (SARS-CoV-2) continues to evolve and new variants emerge. Using nationwide Danish data, we estimate the transmission dynamics of SARS-CoV-2 Omicron subvariants BA.1 and BA.2 within households. Among 22,678 primary cases, we identified 17,319 secondary infections among 50,588 household contacts during a 1-7 day follow-up. The secondary attack rate (SAR) was 29% and 39% in households infected with Omicron BA.1 and BA.2, respectively. BA.2 was associated with increased susceptibility of infection for unvaccinated household contacts (Odds Ratio (OR) 1.99; 95%-CI 1.72-2.31), fully vaccinated contacts (OR 2.26; 95%-CI 1.95-2.62) and booster-vaccinated contacts (OR 2.65; 95%-CI 2.29-3.08), compared to BA.1. We also found increased infectiousness from unvaccinated primary cases infected with BA.2 compared to BA.1 (OR 2.47; 95%-CI 2.15-2.84), but not for fully vaccinated (OR 0.66; 95%-CI 0.57-0.78) or booster-vaccinated primary cases (OR 0.69; 95%-CI 0.59-0.82). Omicron BA.2 is inherently more transmissible than BA.1. Its immune-evasive properties also reduce the protective effect of vaccination against infection, but do not increase infectiousness of breakthrough infections from vaccinated individuals.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark
    Frederik Plesner Lyngse
    Carsten Thure Kirkeby
    Matthew Denwood
    Lasse Engbo Christiansen
    Kåre Mølbak
    Camilla Holten Møller
    Robert Leo Skov
    Tyra Grove Krause
    Morten Rasmussen
    Raphael Niklaus Sieber
    Thor Bech Johannesen
    Troels Lillebaek
    Jannik Fonager
    Anders Fomsgaard
    Frederik Trier Møller
    Marc Stegger
    Maria Overvad
    Katja Spiess
    Laust Hvas Mortensen
    [J]. Nature Communications, 13
  • [2] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
    Tomokazu Tamura
    Daichi Yamasoba
    Yoshitaka Oda
    Jumpei Ito
    Tomoko Kamasaki
    Naganori Nao
    Rina Hashimoto
    Yoichiro Fujioka
    Rigel Suzuki
    Lei Wang
    Hayato Ito
    Yukie Kashima
    Izumi Kimura
    Mai Kishimoto
    Masumi Tsuda
    Hirofumi Sawa
    Kumiko Yoshimatsu
    Yuki Yamamoto
    Tetsuharu Nagamoto
    Jun Kanamune
    Yutaka Suzuki
    Yusuke Ohba
    Isao Yokota
    Keita Matsuno
    Kazuo Takayama
    Shinya Tanaka
    Kei Sato
    Takasuke Fukuhara
    [J]. Communications Biology, 6
  • [3] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
    Tamura, Tomokazu
    Yamasoba, Daichi
    Oda, Yoshitaka
    Ito, Jumpei
    Kamasaki, Tomoko
    Nao, Naganori
    Hashimoto, Rina
    Fujioka, Yoichiro
    Suzuki, Rigel
    Wang, Lei
    Ito, Hayato
    Kashima, Yukie
    Kimura, Izumi
    Kishimoto, Mai
    Tsuda, Masumi
    Sawa, Hirofumi
    Yoshimatsu, Kumiko
    Yamamoto, Yuki
    Nagamoto, Tetsuharu
    Kanamune, Jun
    Suzuki, Yutaka
    Ohba, Yusuke
    Tabata, Kaori
    Yokota, Isao
    Matsuno, Keita
    Takayama, Kazuo
    Tanaka, Shinya
    Sato, Kei
    Fukuhara, Takasuke
    [J]. COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [4] Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
    Arora, Prerna
    Zhang, Lu
    Rocha, Cheila
    Sidarovich, Anzhalika
    Kempf, Amy
    Schulz, Sebastian
    Cossmann, Anne
    Manger, Bernhard
    Baier, Eva
    Tampe, Bjoern
    Moerer, Onnen
    Dickel, Steffen
    Dopfer-Jablonka, Alexandra
    Jaeck, Hans-Martin
    Behrens, Georg M. N.
    Winkler, Martin S.
    Poehlmann, Stefan
    Hoffmann, Markus
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (06): : 766 - 767
  • [5] Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
    Pastorio, Chiara
    Zech, Fabian
    Noettger, Sabrina
    Jung, Christoph
    Jacob, Timo
    Sanderson, Theo
    Sparrer, Konstantin M. J.
    Kirchhoff, Frank
    [J]. CELL HOST & MICROBE, 2022, 30 (09) : 1255 - +
  • [6] Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
    Yu, Jingyou
    Collier, Ai-ris Y.
    Rowe, Marjorie
    Mardas, Fatima
    Ventura, John D.
    Wan, Huahua
    Miller, Jessica
    Powers, Olivia
    Chung, Benjamin
    Siamatu, Mazuba
    Hachmann, Nicole P.
    Surve, Nehalee
    Nampanya, Felix
    Chandrashekar, Abishek
    Barouch, Dan H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (16):
  • [7] Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
    Hiam Chemaitelly
    Houssein H. Ayoub
    Sawsan AlMukdad
    Peter Coyle
    Patrick Tang
    Hadi M. Yassine
    Hebah A. Al-Khatib
    Maria K. Smatti
    Mohammad R. Hasan
    Zaina Al-Kanaani
    Einas Al-Kuwari
    Andrew Jeremijenko
    Anvar Hassan Kaleeckal
    Ali Nizar Latif
    Riyazuddin Mohammad Shaik
    Hanan F. Abdul-Rahim
    Gheyath K. Nasrallah
    Mohamed Ghaith Al-Kuwari
    Adeel A. Butt
    Hamad Eid Al-Romaihi
    Mohamed H. Al-Thani
    Abdullatif Al-Khal
    Roberto Bertollini
    Laith J. Abu-Raddad
    [J]. Nature Communications, 13
  • [8] Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
    Ohashi, Hirofumi
    Hishiki, Takayuki
    Akazawa, Daisuke
    Kim, Kwang Su
    Woo, Joohyeon
    Shionoya, Kaho
    Tsuchimoto, Kana
    Iwanami, Shoya
    Moriyama, Saya
    Kinoshita, Hitomi
    Yamada, Souichi
    Kuroda, Yudai
    Yamamoto, Tsukasa
    Kishida, Noriko
    Watanabe, Shinji
    Hasegawa, Hideki
    Suzuki, Tadaki
    Maeda, Ken
    Fukushi, Shuetsu
    Takahashi, Yoshimasa
    Iwami, Shingo
    Watashi, Koichi
    [J]. ANTIVIRAL RESEARCH, 2022, 205
  • [9] Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
    Chemaitelly, Hiam
    Ayoub, Houssein H.
    AlMukdad, Sawsan
    Coyle, Peter
    Tang, Patrick
    Yassine, Hadi M.
    Al-Khatib, Hebah A.
    Smatti, Maria K.
    Hasan, Mohammad R.
    Al-Kanaani, Zaina
    Al-Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Abdul-Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al-Kuwari, Mohamed Ghaith
    Butt, Adeel A.
    Al-Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Al-Khal, Abdullatif
    Bertollini, Roberto
    Abu-Raddad, Laith J.
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [10] Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
    Wilhelm, Alexander
    Widera, Marek
    Grikscheit, Katharina
    Toptan, Tuna
    Schenk, Barbara
    Pallas, Christiane
    Metzler, Melinda
    Kohmer, Niko
    Hoehl, Sebastian
    Marschalek, Rolf
    Herrmann, Eva
    Helfritz, Fabian A.
    Wolf, Timo
    Goetsch, Udo
    Ciesek, Sandra
    [J]. EBIOMEDICINE, 2022, 82